In Silico Vaccine Design for SARS-CoV-2

With our unparalleled knowledge in the in-silico models, epitope screening and immunology, Creative Biolabs provides high-quality customized in silico vaccine design service to support the rational design for vaccines. Our in silico vaccine development services can help address the challenges and accelerate vaccine design and development of SARS-CoV-2.

In Silico Vaccine Design Services for SARS-CoV-2

The current outbreak of SARS-CoV-2 in China and its subsequent spread to many countries around the world pose a huge threat to global public health, and no vaccine has yet been approved to prevent the disease. Therefore, the development of safe and effective vaccines is very important for controlling SARS-CoV-2. In silico approach can predict B- and T-cell immune epitopes, improve the vaccine design and assess vaccine safety and efficacy, providing potential vaccine candidates for the SARS-CoV-2.

Our in silico vaccine development platform contains epitope screening tools that can be used to identify potential epitopes in protein vaccine targets. Driven by sequence information, structural bioinformatics, and experimental data, these tools can predict peptide/HLA binding, and HLA Class I CD8+ and CD4+T cell epitopes. To provide the optimal amounts of antigen that confers the broadest protection against SARS-CoV-2 infection, our screening tools can identify conserved regions in multiple SARS-CoV-2 strains to help design vaccines with maximum coverage.

We Can Help You：

Increase Chance of Clinical Success

• A flexible, long-established set of tools with wide HLA coverage
• Aid in the development of vaccines with the appropriate immune response
• Identify T and B epitopes and design the vaccines in silico
• Help develop vaccines with an appropriate immune response
• Combine in silico results with in vitro assays to identify promising vaccine candidates
• Expert scientists that will assist in analyzing and interpreting the data and provide advice throughout the process

Save Time and Money in Development

• A strong team of experts helping analyze and interpret the data and provide consultation and advice throughout the vaccine development process
• Rapidly assess vaccine candidates with a high throughput process
• Reduce manual labor using in silico screening to identify peptides as compared to in vitro screening
• Focus R&D resources on a smaller number of vaccine candidates that have a great chance of success in the early stages of development

Creative Biolabs’ in silico vaccine development services support the selection, ranking, optimization and rational design of lead candidates to develop an effective and safe vaccine for SARS-CoV-2. Our vaccine design and development services help reduce the cost of failure and increase the chance of clinical success. If you have any questions about our services, please feel free to contact us.

For Research Use Only. We do not provide direct services or products for patients.